Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.275
-0.095 (-2.17%)
At close: Nov 10, 2026, 4:00 PM EST
4.200
-0.075 (-1.75%)
After-hours: Nov 10, 2026, 5:00 PM EST
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.39 billion as of November 10, 2026. It is the 8,308th most valuable company in the world and the 2,014th biggest in the United States. Its market cap has increased by 32.77% in one year.
Market Cap
1.39B
Enterprise Value
994.25M
1-Year Change
32.77%
Global Rank
Country Rank
#2,014 United States
Category
ChartMarket Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.39B, an increase of 101.75%. That is a compound annual growth rate of 12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.39B | -7.54% |
| Dec 31, 2025 | 1.51B | 324.92% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 1.45B |
| Tyra Biosciences | 1.45B |
| AnaptysBio | 1.45B |
| Kardigan | 1.42B |
| Korsana Biosciences | 1.42B |
| Ascentage Pharma Group International | 1.40B |
| Avalyn Pharma | 1.38B |
| Mineralys Therapeutics | 1.37B |